Barely Significant
← all excerpts

Rapid progression of prostate cancer in men with a BRCA2 mutation.

Br J Cancer · 2008 · PMC2480973 · PMID 18577985

Europe PMCDOI
1
hedged sentence
0.0100
closest p · 0.2× alpha
0.0100
boldest claim

The sentences

highly significantP <0.01actually significant
The median survival from diagnosis was 4.0 years for men with a BRCA2 mutation vs 8.0 years for men with a BRCA1 mutation, and the difference was highly significant ( P <0.01).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.